RADIOHYBRID

Live / Registered — Registered (as of 22 Apr 2025)

What this means for you

Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97695250
Registration number
7772317
Mark type
Stylized text
Filed
29 Nov 2022
Registered
22 Apr 2025
Attorney of record
Andrew D. Bochner

Goods and services

  • Class 001 — Chemicals: Chemicals for use in scientific research, other than for medical or veterinary purposes; diagnostic chemicals for scientific use; Positron Emission Tomography (PET) imaging tracer chemicals for scientific and laboratory use; radioactive elements for scientific purposes; diagnostic scanning agents for in-vivo use other than medical purposes; chemicals for use in molecular imaging for scientific or research use
  • Class 005 — Pharmaceuticals: Medical, pharmaceutical and veterinary preparations for diagnosis, monitoring and treatment of cancer; sanitary preparations for medical use; diagnostic preparations for medical purposes; medical preparations in the nature of biometallic compounds for consumption or injection for use in medical imaging; contrast agents for use in medical imaging; amino acids for medical purposes; radioactive substances for medical purposes; reagents for medical use; Positron Emission Tomography (PET) tracer chemicals for medical use; Positron Emission Tomography (PET) tracer chemicals prepared for ingestion or injection into humans and animals for medical purposes; diagnostic chemicals for medical purposes; Therapeutic pharmaceutical for the treatment of cancer; reagents for medical purposes; diagnostic scanning agents for medical use; pharmaceutical preparations, namely, radiotherapeutic preparations and radio diagnostic preparations; Diagnostic medical preparations for use in molecular imaging; pharmaceutical preparations, namely, radiotherapeutic preparations and radiodiagnostic preparations; pharmaceutical preparations for the treatment of cancer; diagnostic radiopharmaceutical preparations; radiopharmaceutical products, namely, radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceuticals used in the field of nuclear medicine, intended for medical imaging and therapy; Pharmaceutical preparations, namely, alpha- and beta-emitting radionuclides for use in radionuclide therapy; synthetic amino acids for medical purposes, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy; reagents for medical use, namely, use in Positron Emission Tomography (PET) imaging and radionuclide therapy
  • Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design in the field of industrial analysis; industrial analysis and research services in the field of radiopharmaceuticals; design and development of computer hardware and software; product design and development in the field of Positron Emission Tomography (PET) imaging and radionuclide therapy; medical and scientific research in the field of disease diagnosis and treatment; scientific and medical research in the field of molecular imaging; development of molecular imaging products; development of radionuclide therapy products; diagnostic imaging for scientific purposes; scientific imaging services; medical laboratory services; medical and pharmacological research services; scientific research consulting in the field of medical imaging; Medical laboratory services
  • Class 044 — Medical, beauty and agricultural services: Medical clinic services; Positron Emission Tomography (PET) imaging services; medical imaging services; medical analysis for the diagnosis and treatment of persons; medical consultations

Owner

Prosecution history

  • 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 22 Apr 2025 — REGISTERED-SUPPLEMENTAL REGISTER
  • 30 Jan 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 27 Jan 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
  • 24 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 24 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 24 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 23 Jan 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
  • 01 Nov 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 01 Nov 2024 — FINAL REFUSAL E-MAILED
  • 01 Nov 2024 — FINAL REFUSAL WRITTEN
  • 06 May 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 06 May 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 06 May 2024 — ASSIGNED TO LIE
  • 14 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Marksy